Cite
HARVARD Citation
Hasni, S. et al. (n.d.). 183 A phase 1B/2A trial of tofacitinib, an oral janus kinase inhibitor, in systemic lupus erythematosus. Lupus science & medicine. pp. A139-A140. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hasni, S. et al. (n.d.). 183 A phase 1B/2A trial of tofacitinib, an oral janus kinase inhibitor, in systemic lupus erythematosus. Lupus science & medicine. pp. A139-A140. [Online].